Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-025730
Filing Date
2021-05-10
Accepted
2021-05-10 06:14:04
Documents
7
Period of Report
2021-05-10

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210505.htm 6-K 18044
2 EX-99.1 bntx-ex991_7.htm EX-99.1 19941
3 GRAPHIC glbausyvmtlx000001.jpg GRAPHIC 41593
4 GRAPHIC g1enzggjgese000002.jpg GRAPHIC 804
5 GRAPHIC g1enzggjgese000003.jpg GRAPHIC 804
6 GRAPHIC g1enzggjgese000001.jpg GRAPHIC 804
7 GRAPHIC g1enzggjgese000004.jpg GRAPHIC 804
  Complete submission text file 0001564590-21-025730.txt   101398
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21905126
SIC: 2836 Biological Products, (No Diagnostic Substances)